Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

60.50
-0.5621-0.92%
Volume:140
Turnover:9K
Market Cap:9.08M
PE:- -
High:60.50
Open:61.07
Low:60.50
Close:61.07
52wk High:64.69
52wk Low:50.40
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.88
T/O Rate:0.09%
Dividend:0.51
Dividend Rate:0.85%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Dow Jones
·
13 hours ago

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

TIPRANKS
·
13 hours ago

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS
·
14 hours ago

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS
·
14 hours ago

Eli Lilly - Foundayo Shows Smaller Egrf Reduction and Greater Albuminuria Reduction vs Insulin Glargine

THOMSON REUTERS
·
14 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
15 hours ago

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
15 hours ago

Merck, 3M Share Losses Contribute to Dow's 286-Point Drop

Dow Jones
·
16 hours ago

From AI Infrastructure to GLP-1 Drugs, Here are Investment Pros' Favorite Niche ETFs Now

Dow Jones
·
16 hours ago

Judge Denies In Part UnitedHealth's Motion to Dismiss CalPERS Suit

MT Newswires Live
·
17 hours ago

Judge Denies in Part UnitedHealth's Motion to Dismiss CalPERS Suit

MT Newswires Live
·
18 hours ago

Dow Drops 150 Points on Losses for Shares of Sherwin-Williams Co., Merck

Dow Jones
·
18 hours ago

Sector Update: Healthcare

MT Newswires Live
·
18 hours ago

Lilly’s Clazakizumab Trial Pushes Cardiovascular Inflammation Strategy Forward

TIPRANKS
·
19 hours ago

AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence

TIPRANKS
·
19 hours ago

AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline

TIPRANKS
·
19 hours ago

Spyre Gains After Merck's Drug Succeeds in Skin Disease Trial

Reuters
·
Yesterday

Eli Lilly Reports 'Positive' Results From EloraTZP Trial

MT Newswires Live
·
Yesterday

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Yesterday

Adding Lilly's New Drug to Zepbound Helped People Lose up to 23% of Their Weight. but There were More Side Effects.

Dow Jones
·
Yesterday